Skip to content

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06696534
Acronym
MS-Care
Enrollment
1000
Registered
2024-11-20
Start date
2025-05-19
Completion date
2025-12-31
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening for Colon Cancer, Survey and Questionnaire

Keywords

colorectal cancer, screening programme, experience, preference, questionnaire

Brief summary

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are: * Values of experience of participants into screening programme. * Values of preferences of participants for screening methods. Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Interventions

OTHERSurvey using a questionnaire.

Preference questionnaire for colorectal cancer screening methods

Sponsors

SERMAS
CollaboratorUNKNOWN
ULS de Santa Maria
CollaboratorUNKNOWN
ADVANCED MARKER DISCOVERY S.L.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants ages from 50 to 69 years (both included) at the time of informed consent signed. * Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center. * Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion criteria

* Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form. * Participants with a previous colonoscopy in consequence of a FOBT positive result. * Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Design outcomes

Primary

MeasureTime frameDescription
Value of questionnaires into screening programme12 monthsThe percentage of number of answers from each experience and preference questions

Countries

Portugal, Spain

Contacts

Primary ContactMarta Jimenez, PhD
mjimenez@amadix.com+34 637899149

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026